GLP-1 medications are prescription therapies used in medical weight management to support appetite regulation, medical weight management, and sustainable weight loss — when used appropriately and under clinical supervision.
GLP-1 medications mimic the effects of a naturally occurring hormone involved in appetite regulation, digestion, and blood sugar control.
GLP-1 medications are not stimulants, not crash-diet drugs, and not cosmetic weight-loss treatments.
When clinically appropriate, providers may consider evidence-based GLP-1 medications such as:
Evidence-based GLP-1 medication
Evidence-based GLP-1 medication
Why the "right" option depends on you
Your provider reviews your medical history, current medications, and any conditions that may affect safety or tolerability. Certain medical histories may make GLP-1 therapy inappropriate or guide which option is safest.
Lab work may be ordered to better understand your medical weight management and ensure safe prescribing. Labs help provide context for care but do not automatically determine which medication is used.
GLP-1 medications affect appetite and digestion. Your clinician considers factors such as prior medication sensitivity, gastrointestinal symptoms, and lifestyle demands when selecting a medication and dosing approach.
GLP-1 therapy at SCULPT follows a structured, safety-focused philosophy:
Medications prescribed only when clinically appropriate
Dosing starts low and increases gradually
Goal is the lowest effective dose
Adjustments based on response and tolerability
Like all prescription medications, GLP-1 therapies may cause side effects. Commonly discussed effects include:
Common side effect, typically temporary
Feeling satisfied with less food
Digestive system adjustments
Constipation or diarrhea possible
Your clinician provides education on side effect prevention, management strategies, and when to seek medical guidance.
Safety is prioritized over speed or scale.
Lab work may be ordered when clinically indicated to assess baseline medical weight management and support safe prescribing.
Lab decisions are individualized and reviewed directly by your clinician — not automatically generated.
The duration of GLP-1 therapy varies by individual. Some patients use GLP-1 medications short-term, while others benefit from longer-term use as part of metabolic disease management.
Your clinician will discuss expectations, reassessment timelines, and maintenance strategies with you.
If you're interested in learning whether GLP-1 therapy may be appropriate for you, start with a clinician-led evaluation.
Medical protocols backed by research
MA-licensed medical providers
Lab-guided, monitored care